BRUSSELS/LONDON, Sept 22 (Reuters) - Shire’s (SHP.L) 428 million-euro ($569 million) takeover of Belgian drugmaker Movetis (MOVET.BR) moved a step closer on Wednesday after founding shareholder Johnson & Johnson (JNJ.N) accepted the UK firm’s cash offer for its 13 percent stake.